Anti-erbB-2 (Her-2/neu) (Margetuximab) - 1.0 mg LT220-1.0mg from Leinco Technologies, Inc.

Product Specs
ItemAnti-erbB-2 (Her-2/neu) (Margetuximab) - 1.0 mg
CompanyLeinco Technologies, Inc.
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberLT220-1.0mg
Antibody TypeRecombinant Antibody
ReactivityHuman
FormatThis biosimilar antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration
ImmunogenHuman erbB2/EGFR2/CD340
TargeterbB-2
Conjugate/TagUnconjugated
Quantity1.0 mg
Concentration≥ 5.0 mg/ml
ClonalityMonoclonal Antibody
ApplicationsELISA, FA, FC, IP, WB
CloneMGAH22
IsotypeHuman IgG1κ
Purity≥95% by SDS Page, ≥98% monomer by analytical SEC
NCBI Full Gene Nameerb-b2 receptor tyrosine kinase 2
NCBI Gene AliasesCD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19, NEU, NGL, TKR1, VSCN2, c-ERB-2, c-ERB2, p185(erbB2)
Research AreaBiosimilars, Cancer, Immuno-Oncology, Immunology